Results 101 to 110 of about 1,264,680 (377)

Mouse model of ocular hypertension with retinal ganglion cell degeneration

open access: yesPLoS ONE, 2019
Objectives Ocular hypertension is a primary risk factor for glaucoma and results in retinal ganglion cell (RGC) degeneration. Current animal models of glaucoma lack severe RGC cell death as seen in glaucoma, making assessment of physiological mediators ...
Ryo Mukai   +10 more
semanticscholar   +1 more source

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

open access: yesAdvanced Functional Materials, EarlyView.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth   +2 more
wiley   +1 more source

Alterations in retinal pulse wave velocity under experimental ocular hypertension [PDF]

open access: green, 2023
Mahnaz Shahidi   +5 more
openalex   +1 more source

Evidence of Hypoxic Glial Cells in a Model of Ocular Hypertension

open access: yesInvestigative Ophthalmology and Visual Science, 2019
Purpose Reoxygenation after hypoxia can increase reactive oxygen species and upregulate autophagy. We determined, for the first time, the impact of elevated IOP on hypoxia induction, superoxide accumulation, and autophagy in a bead model of glaucoma ...
A. H. Jassim, D. Inman
semanticscholar   +1 more source

Hipertensión arterial : aspectos angiográficos del fondo ocular en el perro. Estudios de 24 casos [PDF]

open access: yes, 1999
Se estudian los hallazgos clínicos, oftalmoscópicos y angiofluoresceinográficos del fondo ocular en 24 perros diagnosticados de hipertensión arterial sistémica.
Cascales, Mª J.   +1 more
core  

Canaloplasty in the Treatment of Open-Angle Glaucoma: A Review of Patient Selection and Outcomes. [PDF]

open access: yes, 2018
Canaloplasty is a relatively new non-penetrating surgery for the reduction of intraocular pressure in patients affected by glaucoma. The technique uses a microcatheter to perform a 360 º cannulation of Schlemm's canal and leaves in place a tension suture
Brusini, Paolo   +5 more
core   +2 more sources

Biosupercapacitors for Human‐Powered Electronics

open access: yesAdvanced Functional Materials, EarlyView.
Biosupercapacitors are emerging as biocompatible and integrative energy systems for next‐generation bioelectronics, offering rapid charge–discharge performance and mechanical adaptability. This review systematically categorizes their applications from external to organ‐level systems and highlights their multifunctional roles in sensing, actuation, and ...
Suhyeon Kim   +7 more
wiley   +1 more source

OCULAR HYPERTENSION - RISK FACTORS AND THERAPY?

open access: yesSanamed, 2015
Introduction/Aim: The goal of our study was to analyze the epidemiological`s characteristics of ocular hypertension, as well as the influence of chronic risk factors on glaucoma development (conversion in glaucoma).
Janićijević Katarina   +3 more
doaj   +1 more source

Cyclodialysis cleft repair with goniotomy for the control of post-operative ocular hypertension

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: In this case of iatrogenic cyclodialysis cleft, we describe a technique in which a nasal goniotomy is coupled with indirect cyclodialysis cleft (CDC) repair in order to minimize acute post-operative ocular hypertension, which is common following
Lorraine M. Provencher, Manjool M. Shah
doaj   +1 more source

Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension

open access: yesDrugs, 2018
Latanoprostene bunod ophthalmic solution 0.024% (hereafter referred to as latanoprostene bunod 0.024%) [Vyzulta™] is a nitric oxide (NO)-donating prostaglandin F2α analogue approved in the USA for the reduction of intraocular pressure (IOP) in patients ...
Sheridan M. Hoy
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy